All NIH Funding Opportunities and Notices

• HHS Small Business Innovation Research (SBIR) Program Contract Solicitation (PHS 2018-1) Now Available
  (NOT-OD-17-089)
  National Institutes of Health
  

• Notice to Expire the "Tobacco Regulatory Science (R01)" RFA-OD-17-007
  (NOT-OD-17-091)
  National Institutes of Health
  

• Notice to Expire the "Tobacco Regulatory Science Small Grant Program for New Investigators (R03)" RFA-OD-17-008
  (NOT-OD-17-092)
  National Institutes of Health
  

• Notice to Expire the "Tobacco Regulatory Science (R21)" RFA-OD-17-009
  (NOT-OD-17-093)
  National Institutes of Health
  

• Notice of Change in the Expiration Date for PAR-14-268 "International Research Collaboration on Alcohol and Alcoholism (U01)
  (NOT-AA-17-008)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of Early Expiration of PAR-15-281 "Multidisciplinary Studies of HIV and Aging (R03)"
  (NOT-AG-17-011)
  National Institute on Aging
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute of Mental Health
  

• Notice of NIA Participation in PAS-16-033 "Stimulating Hematology Investigation: New Endeavors (SHINE) (R01)" Aging and Hematopoiesis
  (NOT-AG-17-012)
  National Institute on Aging
  

• Notice of NIA Participation in PAS-15-168 "New Directions in Hematology Research (SHINE-II) (R01)" Aging and Hematopoiesis
  (NOT-AG-17-013)
  National Institute on Aging
  

• Notice of Clarification to the Award Budget for PAR-16-446 "NIAMS Clinical Trial Planning Grant (R34)
  (NOT-AR-17-018)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

• Notice of NCI's Participation on PA-17-135, Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R01)
  (NOT-CA-17-069)
  National Cancer Institute
  

• Notice of NCI's Participation on PA-17-132, Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R21)
  (NOT-CA-17-070)
  National Cancer Institute
  

• Notice of NCI's Participation on PA-17-134, Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R03)
  (NOT-CA-17-071)
  National Cancer Institute
  

• Notice of Change to the Eligibility of Foreign Components in PA-17-112, " Neuroscience Research on Drug Abuse (R21)"
  (NOT-DA-17-042)
  National Institute on Drug Abuse
  

• Notice of NIDA's Participation in PAR-15-315 "Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects in Translational Research (R21)"
  (NOT-DA-17-046)
  National Institute on Drug Abuse
  

• Notice of NIDA's Participation in PAR-16-330 "Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01)"
  (NOT-DA-17-047)
  National Institute on Drug Abuse
  

• Notice of NIDA's Participation in PAR-16-331 "Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01)"
  (NOT-DA-17-048)
  National Institute on Drug Abuse
  

• Request for Information (RFI): Patient and Family Needs and Requirements to be Addressed by the Small Business Programs of the National Institute on Drug Abuse (NIDA)
  (NOT-DA-17-049)
  National Institute on Drug Abuse
  

• Notice of Revised Reporting Requirement for Appointing Participants in PAR-17-209 "Bridges to the Doctorate (R25)"
  (NOT-GM-17-012)
  National Institute of General Medical Sciences
  

• Notice of Revised Reporting Requirement for Appointing Participants in PAR-17-210 "Bridges to the Baccalaureate (R25)"
  (NOT-GM-17-013)
  National Institute of General Medical Sciences
  

• Notice of Change: Requirement for use of xTrain by Grantees of "Bridges to the Doctorate (R25)" and "Bridges to the Baccalaureate (R25)" Programs
  (NOT-GM-17-014)
  National Institute of General Medical Sciences
  

• Notice of Intent to Publish a Funding Opportunity Announcement for NIH Science Education Partnership Award (SEPA) (R25)
  (NOT-GM-17-015)
  National Institute of General Medical Sciences
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Programs to Increase Diversity among Individuals Engaged in Health Related Research (PRIDE) Summer Institutes (R25)
  (NOT-HL-17-527)
  National Heart, Lung, and Blood Institute
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Programs to Increase Diversity among Individuals Engaged in Health Related Research (PRIDE) Coordinating Center (U24)
  (NOT-HL-17-528)
  National Heart, Lung, and Blood Institute
  

• Notice of Change to Key Dates for RFA-NS-17-024 "Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites) (U24)
  (NOT-NS-17-035)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Informational Webinar for the NINDS Parkinson's Disease Biomarkers Program (PDBP) - PAR-16-112 (U01)
  (NOT-NS-17-036)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Change of the Review and Selection Process of RFA-RM-17-007 NIH Director's Transformative Research Awards (R01)
  (NOT-RM-17-035)
  NIH Roadmap Initiatives
  

• Request for Information: Opportunities and Challenges for Platform Vector Human Gene Therapy Trials in Rare Diseases
  (NOT-TR-17-019)
  National Center for Advancing Translational Sciences
  

• Notice of Clarification to PAR-17-035 "Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44)"
  (NOT-TR-17-020)
  National Center for Advancing Translational Sciences
  

• Notice of Clarification to PAR-17-036: Platform Delivery Technologies for Nucleic Acid Therapeutics (R41/R42)
  (NOT-TR-17-021)
  National Center for Advancing Translational Sciences
  

• Notice of Change to Key Dates for "Global Brain and Nervous System Disorders Research Across the Lifespan (R21)"
  (NOT-TW-17-006)
  John E. Fogarty International Center
  National Institute of Dental and Craniofacial Research
  

• Notice of Change to Key Dates for "Global Brain and Nervous System Disorders Research Across the Lifespan (R01)"
  (NOT-TW-17-007)
  John E. Fogarty International Center
  National Eye Institute
  National Institute on Aging
  National Institute on Deafness and Other Communication Disorders
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Office of Dietary Supplements
  

• Central Neural Mechanisms of Age-Related Hearing Loss (R01)
  (RFA-AG-18-017)
  National Institute on Aging
  National Institute on Deafness and Other Communication Disorders
  Application Receipt Date(s): November 8, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  

• BRAIN Initiative: New Concepts and Early - Stage Research for Large - Scale Recording and Modulation in the Nervous System (R21)
  (RFA-EY-17-002)
  National Eye Institute
  National Center for Complementary and Integrative Health
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): October 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  

• Re-Competition of Global Network for Womens and Childrens Health Research (UG1)
  (RFA-HD-18-009)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): November 27, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  

• CAPSTONE Centers for Multidisciplinary Research in Child Abuse and Neglect (P50)
  (RFA-HD-18-012)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): November 27, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  

• The NHGRI Genomic Data Science Analysis, Visualization, and Informatics Lab-space (AnVIL) (U24)
  (RFA-HG-17-011)
  National Human Genome Research Institute
  Application Receipt Date(s): November, 9, 2017), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  

• Tobacco Regulatory Science Small Grant Program for New Investigators (R03)
  (RFA-OD-17-012)
  National Institutes of Health
  U.S. Food and Drug Administration, Center for Tobacco Products
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  Office of Disease Prevention
  Application Receipt Date(s): September 18, 2017, February 13, 2018, July 17, 2018, February 13, 2019 ), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  

• Tobacco Regulatory Science (R01)
  (RFA-OD-17-013)
  National Institutes of Health
  U.S. Food and Drug Administration, Center for Tobacco Products
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  Office of Disease Prevention
  Application Receipt Date(s): September 18, 2017, February 13, 2018, July 17, 2018, February 13, 2019 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  

• Tobacco Regulatory Science (R21)
  (RFA-OD-17-014)
  National Institutes of Health
  U.S. Food and Drug Administration, Center for Tobacco Products
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  Office of Disease Prevention
  Application Receipt Date(s): September 18, 2017, February 13, 2018, July 17, 2018, February 13, 2019 ), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  

• Administrative Supplements for the U.S.-Japan Brain Research Cooperative Program (BRCP) - U.S. Entity (Admin Supplement)
  (PA-17-326)
  National Institute of Neurological Disorders and Stroke
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Institute on Aging
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  Application Receipt Date(s): September 18, 2017; September 18, 2018; September 18, 2019, by 5:00 PM local time of applicant organization, by 5:00 PM local time of applicant organization.
  
  

• NIMH Administrative Supplement Program to Enable Continuity of Research Experiences of MD/PhDs during Clinical Training (Admin Supp)
  (PA-17-328)
  National Institute of Mental Health
  Application Receipt Date(s): NIMH accepts and reviews applications on a continuous basis until April 1 of each fiscal year. Applications received after April 1 will be considered for funding in the next fiscal year. Earlier submission is strongly encouraged. Applications for FY 18 funds should be submitted no later than April 1, 2018. Applications for FY 19 funds should be submitted no later than April 1, 2019. Applications for FY 20 funds should be submitted no later than April 1, 2020 Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Using Small Molecules and Molecular Genetics to Identify Novel Targets and Mechanisms Contributing to Tumor Immune Evasion (R01)
  (PA-17-330)
  National Cancer Institute
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  
  

• First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Devices for Psychiatric Disorders (U01)
  (PAR-17-327)
  National Institute of Mental Health
  Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  
  

• NIAID Physician-Scientist Pathway to Independence Award (K99/R00)
  (PAR-17-329)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  
  

• Discovery of Small Molecule Immunomodulators for Cancer Therapy (R01)
  (PAR-17-331)
  National Cancer Institute
  Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  
  

• Small Grants on Primary Immunodeficiency Diseases (R03)
  (PAR-17-332)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  
  

• Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R21)
  (PAR-17-333)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  
  

  Past Tables of Contents

Department of Health and Human Services

National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892